Product image of Monozeclar (Clarithromycin) supplied by GNH India

Monozeclar

Active Ingredient:
Clarithromycin
Origin:
EU

Monozeclar (Clarithromycin)

Clarithromycin, the active ingredient in Monozeclar, is a macrolide antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute sinusitis, bronchitis, skin infections, and is used in combination regimens for Helicobacter pylori eradication.

GNH India supplies Monozeclar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable supply chains, comprehensive documentation, and responsive technical support.

Manufacturer / TM Owner

Viatris Medical

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Clarithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, ENT, skin, and gastrointestinal systems.

  • Community‑acquired pneumonia: eliminates causative bacteria and improves clinical recovery.
  • Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
  • Acute bacterial bronchitis: relieves cough and eradicates the pathogen.
  • Skin and soft tissue infections: treats cellulitis and other bacterial skin conditions.
  • Helicobacter pylori eradication (in combination therapy): contributes to successful bacterial clearance as part of triple‑therapy regimens.

How It Works

  • Clarithromycin binds to the 50S subunit of bacterial ribosomes, inhibiting translocation of the peptidyl‑tRNA. This blocks protein synthesis, leading to bacteriostatic activity against susceptible Gram‑positive and some Gram‑negative organisms, and contributes to bacterial eradication when concentrations are sufficient.

Side Effects

Adverse reactions may occur with clarithromycin therapy.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: frequent loose stools.
  • Abdominal pain: cramping or discomfort.
  • Taste disturbance: altered or metallic taste.
  • Vomiting: occasional emesis.
  • Headache: mild to moderate.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • QT prolongation: may lead to cardiac arrhythmias.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Clostridioides difficile‑associated diarrhea: severe colitis.
  • Cardiac arrhythmias: including torsades de pointes.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.

Precautions & Warnings

Use clarithromycin with caution and follow medical guidance.

  • Renal or hepatic impairment: adjust therapy under professional supervision.
  • Pregnancy and lactation: prescribe only if benefits outweigh potential risks.
  • Drug resistance: limit use to confirmed bacterial infections to avoid resistance development.
  • Cardiac risk: avoid in patients with known QT‑interval prolongation.
  • Drug interactions: review all concomitant medications for potential interactions.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Clarithromycin can interact with several medicines; monitoring is essential.

Major Interactions (Avoid)

  • Erythromycin: additive risk of QT prolongation.
  • Cisapride: may cause serious cardiac arrhythmias.
  • Theophylline: clarithromycin inhibits metabolism, raising serum levels.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR; monitor coagulation parameters.
  • Statins (lovastatin, simvastatin): heightened risk of myopathy; check creatine kinase levels.

Frequently Asked Questions

Monozeclar, containing clarithromycin, is indicated for community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial bronchitis, skin and soft‑tissue infections, and as part of combination therapy for Helicobacter pylori eradication.

Clarithromycin binds to the 50S ribosomal subunit of susceptible bacteria, blocking the translocation step of protein synthesis. This inhibition halts bacterial growth and can lead to bacterial death when drug concentrations are high enough.

The dosage of Monozeclar is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local treatment guidelines. Patients should follow the prescriber’s instructions precisely.

Safety data for clarithromycin in pregnancy are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk. Breastfeeding mothers should consult a healthcare professional before use.

Enquiries for Monozeclar can be submitted on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monozeclar (clarithromycin) shares the macrolide class with drugs such as azithromycin and erythromycin. Clarithromycin generally offers a broader spectrum against certain Gram‑positive organisms and higher tissue penetration, but it may have more drug‑interaction potential, especially with medications metabolized by CYP3A4.

Monozeclar tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect them from excess moisture, heat and direct sunlight to maintain stability.

Monozeclar is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescribing clinician’s guidance regarding timing relative to meals.

Serious risks include severe allergic reactions such as anaphylaxis, QT‑interval prolongation leading to potentially life‑threatening arrhythmias, hepatic dysfunction, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience symptoms like rash, palpitations, jaundice, or persistent diarrhea.

Monozeclar is contraindicated in patients with known hypersensitivity to clarithromycin or other macrolides, and in individuals with a history of significant QT prolongation or ventricular arrhythmias. Caution is also advised for patients taking drugs that strongly interact with clarithromycin.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clarithromycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT